NYSE · Consumer Cyclical · Personal Services · USA
Medifast Inc is a micro cap company (market value under $300 million) in the Personal Services industry.
Medifast is a health and wellness company offering a coach-guided lifestyle system designed to address metabolic health. The company provides scientifically developed products, personalized coaching from independent contractors, community support, and habit-creation frameworks to help clients achieve lasting health improvements. Medifast operates through a network of independent coaches who support clients and market products primarily through word-of-mouth and social media.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Medifast Inc stock.
Undervalued: intrinsic value $41.93 per share, market price $12.15, margin of safety 71.0% (as of 2026-10-30).
Its through-the-cycle earnings (11.7% median margin), capitalised at 8.4% with no growth, values the shares at $41.93; the price of $12.15 is 71% below that value.
Leak Score: 56/100 on 8 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 13 Personal Services stocks
MED is undervalued (as of the 2026-10-30 close). Its through-the-cycle earnings (11.7% median margin), capitalised at 8.4% with no growth, values the shares at $41.93; the price of $12.15 is 71% below that value.
$41.93 per share (as of the 2026-10-30 close), against a market price of $12.15. That is a margin of safety of 71.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
56 out of 100, which we rate "Weak Signal", on 8 of 12 value investing signals.